STAT+: Investors cheer Compass’ psilocybin data

STAT News · Feb 18, 2026 · Collected from RSS

Full Article

And other biotech news brought to you by The Readout Good morning. I’ve fallen into a rabbit hole reading about curling after the Canada cheating allegations at the Olympics, otherwise known as “boopgate.” Let me know your thoughts on whether the Canadian players cheated. Onto the news. FDA to Moderna: Never mind That didn’t take long. Moderna said this morning that the FDA will now review its experimental mRNA flu vaccine, reversing its decision denying a review because of a dispute over the vaccine’s clinical trial design. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in View All Plans To read the rest of this story subscribe to STAT+. Subscribe National Biotech Reporter Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70.